| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2151648 | Neoplasia | 2010 | 8 Pages |
Abstract
Conclusions. This study shows that the combination of PTK/ZK and cetuximab is well tolerated with only slightly overlapping toxicity profiles and has antitumor activity.
Keywords
EGFRCmaxAUC0-24MTDVEGFRDLTCTCAEMaximum tolerated dosemaximum observed plasma concentrationdose-limiting toxicityInformed consentNSCLCadverse eventpharmacokineticCommon Terminology Criteria for Adverse Eventsnon-small cell lung carcinomavascular endothelial growth factor receptorEpidermal growth factor receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marlies H.G. Langenberg, Petronella O. Witteveen, Nienke A.G. Lankheet, Jeanine M.L. Roodhart, Hilde Rosing, Ingeborg J.G.M. van den Heuvel, Jos H. Beijnen, Emile E. Voest,